News

title

Manhattan Scientifics Announces Agreement to Spin-Off and IPO its Senior Scientific Unit

November 29, 2016

MHTX announces that it is implementing a plan to have Senior Scientific, the company’s cancer diagnostic unit, pursue an IPO and listing on the Australian Stock Exchange (ASX).

Read
title

Ex-GE Healthcare CTO Michael J. Harsh Joins Manhattan Scientifics Advisory Board

March 29, 2016

MHTX announced today that Michael J. Harsh, former VP & Chief Technology Officer for GE Healthcare and a recognized global expert on medical imaging technology, has joined the Company’s Science and Technology Advisory Board.

Read
title

Senior Scientific and Weill Cornell Medicine to Pursue Non-Invasive Prostate Cancer Detection

February 16, 2016

Manhattan Scientifics, Inc. announced that its wholly-owned subsidiary Senior Scientific, LLC, has established a research collaboration with Weill Cornell Medicine.

Read
title

Senior Scientific Teams Up With University of Michigan On In Vivo Breast Cancer Diagnostic

January 13, 2016

Manhattan Scientifics, Inc. announced today that its Senior Scientific unit, developing a platform for the early detection of cancer and other human diseases, has established a Research Collaboration with The University of Michigan Medical School.

Read
title

Senior Scientific Extends Collaboration with MD Anderson Cancer Center

December 14, 2015

Manhattan Scientifics, Inc. announced today that its Senior Scientific, LLC unit, developing a platform for the early detection of cancer and other human diseases, has renewed its Collaboration Agreement with The University of Texas MD Anderson Cancer Center, establishing a multi-year program with extended scope.

Read
title

MHTX Announces Chinese Patent Issued for the Early Cancer Detection Technology Platform

October 26, 2015

Senior Scientific, LLC, a unit of Manhattan Scientifics and a developer of nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the Company has recently been granted a patent by the Chinese Patent Office.

Read
title

Manhattan Scientifics, Inc. Announces Stock Repurchase Program

August 26, 2015

MHTX announced that it is initiating a share repurchase program. MHTX's Board of Directors designated a program to repurchase, from time to time, at management's discretion, shares of the Company's common stock.

Read
title

MHTX Announces Issuance of Additional Patent Covering Detection and Imaging of Cancer Cells

August 10, 2015

NEW YORK--MHTX announced today that its Senior Scientific, LLC unit, has been granted an additional US Patent for its MRX™ cancer detection technology.

Read
title

Manhattan Scientifics Engages Services of Torreya Partners

July 16, 2015

NEW YORK--Manhattan Scientifics, Inc. today announced the engagement of Torreya Partners and its professional services sister company, Torreya Insights.

Read
title

A Letter from the New President of Senior Scientific LLC

May 07, 2015

Cancer continues to be one of the leading causes of mortality globally. Despite technical advances in science and medicine we still lack effective forms of therapy...
Read
title

Letter to Shareholders

April 20, 2015

MHTX owns and is commercializing two nanotechnology businesses: nanostructured metals through our Metallicum subsidiary, and nanotechnology for the very early detection of cancers through Senior Scientific.

Read
title

Manhattan Scientifics Announces Return of Marvin Maslow as Chairman of the Board

March 25, 2015

NEW YORK--Manhattan Scientifics, Inc. announced today that Marvin Maslow, founder of MSI, has re-joined the Company’s Board of Directors as Chairman.

Read
title

MHTX to Immediately Receive $8M as it Reacquires its Nano-Structured Metals Tech & Related IP

February 18, 2015

NEW YORK--Manhattan Scientifics, Inc. has reacquired all rights in its nano-structured metals technology from its former Licensee whose strategic corporate priorities had changed. The agreement includes a one-time payment to Manhattan of $8 million, the assignment to Manhattan of all related IP and the transfer of ownership of various ECAP machinery and equipment used in the manufacturing process of nano-structured metals.

Read
title

MHTX Recruits Robert R. Proulx as New President and COO for Its Senior Scientific Subsidiary

January 14, 2015

MHTX has recruited Robert R. Proulx (pronounced “Pru”) to the position of President and COO of its Senior Scientific LLC subsidiary, effective January 12.

Read
title

Manhattan Scientifics Announces Expansion of Executive Team at Its Senior Scientific Subsidiary

December 30, 2014

MHTX is recruiting a seasoned executive to oversee Senior Scientific’s next stage of product development for its MRX diagnostic tech for the early detection of cancer.

Read
title

Manhattan Scientifics Completes $2.0 Million Equity Raise

November 21, 2014

MHTX completed a $2.0 million equity raise. Proceeds will primarily be used to fund the advancement of its MRX cancer diagnostic tech being developed by Senior Scientific.

Read
title

MHTX’s Unparalleled Cancer Measurement Technology Featured in MD Anderson Presentation

October 08, 2014

Senior Scientific, is currently collaborating with The University of Texas MD Anderson Cancer Center to advance, demonstrate and validate a cancer detection and measurement technology.

Read
title

MHTX Issues Follow Up Report to Shareholders - “Pushing the Limits of Cancer Detection”

October 02, 2014

Three months ago Manhattan Scientifics announced the delivery of its 1st breakthrough cancer measurement instrument to M.D. Anderson Cancer Center in Houston.

Read
title

Manhattan Scientifics Reaches the Fork (Falk) in the Road

August 20, 2014

Spencer Falk, today announced that he would lead the commercialization of early cancer detection technology for Senior Scientific, a division of Manhattan Scientifics.

Read
title

Pushing the Limits of Cancer Detection

June 10, 2014

ALBUQUERQUE, N.M.-- Manhattan Scientifics, Inc. announced today that it has delivered its break-through, cancer measurement instrument to The University of Texas M.D. Anderson Cancer Center in Houston, TX.

Read
title

PrecisionMRX® Nanoparticle Production Process Ready

April 14, 2014

Building upon local relationships, Senior Scientific is stepping into the commercial space with first product introductions through Azano Biotech.

Read
title

Our First Major Product: the NanoMRX™ II

March 19, 2014

The overarching mission for February has been to get the 9 Channel System up and running. We are delighted to be delivering this extraordinary device to our collaborators at MD Anderson.

Read
title

MHTX Announces Commercial Introduction Of NanoMRX Precision Nanoparticles

March 18, 2014

MHTX announced today a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.

Read
title

MHTX Announces Collaboration with MD Anderson Cancer Center

January 27, 2014

MHTX executed an agreement to collaborate with The University of Texas MD Anderson Cancer Center (MDACC).

Read
title

Senior Scientific Announces Issuance of U.S. Patent

May 23, 2013

U.S. Patent No. 8,447,379 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof."

Read
title

Manhattan Scientifics Announces Receipt of $2.5M Commitment to Build Breakthrough Cancer Detection

April 09, 2013

MHTX announced today that it received the initial $1M of a $2.5M commitment to build the first generation of its advanced cancer detection devices.

Read
title

Cancer Research: NFCR Cites MHTX’s Early Cancer Detection Tech as Research Breakthrough for 2012

January 07, 2013

The National Foundation for Cancer Research has listed the cancer imaging technology developed by Senior Scientific as a "2012 Research Breakthrough."

Read
title

MHTX Achieves Significant Milestones in Pursuit of its Early Cancer Detection & Treatment Technology

August 13, 2012

MHTX announced today the achievement of several critical milestones in the development of its proprietary technology for the early detection & treatment of cancer.

Read
title

Comparison of SQUID-detected magnetic relaxometry and MRI

May 04, 2012

Both nanomagnetic relaxometry and magnetic resonance imaging (MRI) can be used to detect and locate targetedmagnetic nanoparticles, noninvasively...

Read
title

National Foundation for Cancer Research Funds Novel Approach to Early Detection of Ovarian Cancer

February 23, 2012

The National Foundation for Cancer Research has awarded a grant to Dr. Robert C. Bast, Jr. of The University of Texas MD Anderson Cancer Center...

Read
title

Summary of Memorial Sloan Kettering Advisory Board Meeting

January 12, 2012

It is with great pleasure that I write this synopsis of the advisory board meeting that I had the honor to chair on October 31st, 2011.

Read
title

Fortune: Manhattan Scientifics is a Leader in the Race for a Better Mammogram

December 19, 2011

NEW YORK--()--“The race is on for a better mammogram” states the December 19th headline in Fortune Magazine’s (online) story by Sierra Jiminez.

Read
title

Manhattan Scientifics CEO Issues Letter to Shareholders

December 15, 2011

Thank you for your investment in Manhattan Scientifics. I want to personally and corporately thank all our shareholders for their encouragement. 

Read
title

Alzheimer’s Disease Patent Issued to New Mexico Physicist Edward R. Flynn, Ph.D

December 06, 2011

Senior Scientific, LLC announced today that it has been granted U.S. patent 8,060,179, titled "Biomagnetic Detection and Treatment of Alzheimer's Disease".

Read
title

“Breast Cancer Research” Publishes Key Study; Cancer-Sensing Technology is Radiation-Free

October 31, 2011

Manhattan Scientifics announced today that "Breast Cancer Research," an international, peer-reviewed online journal, has published results of a study...

Read
title

Watching Cancer Cells Disappear During Therapy

October 13, 2011

Manhattan Scientifics announced today that the National Cancer Institute (NCI) has funded a grant for its Senior Scientific, LLC unit, for the use of its proprietary...

Read
title

Profiles In Versatility

October 11, 2011

A cabal of cacophonic college kids inspired Shahriar Afshar to become an entrepreneur. It was 2004, and the physicist was serving as a visiting professor...

Read
title

Dr. Edward Flynn Recognized In American Physics Society Journal For His Work In Cancer Detection

October 04, 2011

Dr. Edward R. Flynn Ph.D., founder of Senior Scientific, LLC, a company owned by Manhattan Scientifics, has been prominently mentioned in...

Read
title

Breast Cancer: How Far Have We Come?

October 01, 2011

An easy at-home test? Drugs that slash your risk? These aren’t science fiction they’re real advances that are revolutionizing the way we find...

Read
title

Manhattan Scientifics Names V. Gerald Grafe To Commercialize Senior Scientific

August 02, 2011

Manhattan Scientifics today announced it has named V. Gerald Grafe to lead the commercialization of Senior Scientific. On June 6th...

Read
title

MHTX Acquires Senior Scientific to Speed Applications of Early Cancer Detection and Treatment

June 06, 2011

In a move to accelerate applications of a novel cancer detection and treatment technology, Manhattan Scientifics today announced that it has acquired all...

Read
title

Business Weekly unveils “Who’s Who in Tech” Honorees

April 04, 2011

The Business Weekly has selected 25 honorees for its 2011 “Who’s Who in Technology” awards. The group includes people who have made a contribution...

Read
title

Novel magnetic mechanism for early cancer detection under development at CINT

April 01, 2011

To materials chemist Dale Huber, most people remain unaware they have cancer precisely when the knowledge could help them most...

Read
title

Nanotechnology Cancer Detection Technology Moves To Clinical Trial in Gray Sheets

March 14, 2011

A first-in-man clinical trial to measure very small levels of residual leukemia cells using a unique nanotechnology based magnetic imaging...

Read
title

Breast Cancer Detection Technology Licensed to Manhattan Scientifics Covered by Wall Street Journal

March 02, 2011

Yesterday's Wall Street Journal (March 1) published a lead article on page D1 which described the research by Dr. Edward R. Flynn, of Senior Scientific LLC.

Read
title

Manhattan Scientifics and Dr. Edward Flynn Interviewed by Bloomberg Radio to Discuss Early Detection

January 27, 2011

Technology exists today that is capable of detecting breast cancer up to three years earlier...

Read
title

Bloomberg Podcast of Interview with Dr. Flynn

January 15, 2011

Flynn’s technology is a non-radiation diagnostic that uses magnetic, nano-sized breast cancer targeting antibodies which bind only to cancer, and can detect and localize a tumor...

Read
title

Senior Scientific’s Technology Featured in TMD

December 28, 2010

Magnetism has special properties that can be utilized to detect disease by combining nanotechnology and ultra-sensitive magnetic sensors. Senior Scientific LLC, Albuquerque, NM, has been developing...

Read
title

Grants Issued for Very Early Cancer Detection & Treatment

November 09, 2010

Manhattan Scientifics, Inc. (OTCBB: MHTX) announced that Senior Scientific LLC is the recipient of four grants totaling $702,899...

Read
title

Beyond Flip-Of-A-Coin Breast Cancer Diagnosis

July 27, 2010

Nanotechnology and the emerging field of nanomedicine promise to change how--and when--we can detect breast cancer. In development now is a non-radiation diagnostic that uses magnetic...

Read
title

CINT Annual Report 2009

January 21, 2010

We are pleased to present this inaugural Annual Report from the Center for Integrated Nanotechnologies. The goal of this and future reports is to reach out to our entire stakeholder community...

Read

Media Inquiries